HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) COO Jon Foster sold 21,713 shares of the company’s stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the sale, the chief operating officer directly owned 10,000 shares in the company, valued at approximately $4,949,500. This trade represents a 68.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
HCA Healthcare Trading Down 0.1%
Shares of HCA stock opened at $494.44 on Monday. The firm’s 50 day moving average is $443.66 and its 200 day moving average is $445.25. The stock has a market capitalization of $103.28 billion, a P/E ratio of 16.38, a PEG ratio of 1.65 and a beta of 1.11. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. During the same period in the previous year, the business earned $6.96 earnings per share. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. On average, equities analysts predict that HCA Healthcare, Inc. will post 30.15 EPS for the current year.
HCA Healthcare Announces Dividend
Hedge Funds Weigh In On HCA Healthcare
A number of hedge funds and other institutional investors have recently modified their holdings of HCA. BlackRock Inc. purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $5,069,974,000. Legal & General Group Plc bought a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $410,992,000. Jupiter Topco LLC purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $371,138,000. Wellington Management Group LLP raised its holdings in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares in the last quarter. Finally, Bank of America Corp DE purchased a new stake in HCA Healthcare in the second quarter worth $238,457,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts have weighed in on HCA shares. KeyCorp upped their target price on HCA Healthcare from $435.00 to $490.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 28th. The Goldman Sachs Group dropped their price target on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research report on Tuesday, July 28th. Leerink Partners reissued an “outperform” rating and set a $492.00 price objective on shares of HCA Healthcare in a report on Friday, September 18th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 14th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a research report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $480.13.
View Our Latest Stock Analysis on HCA Healthcare
Key Stories Impacting HCA Healthcare
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
- Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
- Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
- Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
- Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
- Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
- Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement
About HCA Healthcare
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.
The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.
Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
